[Skip to Navigation]
Sign In
Comment & Response
November 18, 2020

The Role of Bariatric Surgery in Prevention of Kidney Disease Progression in Moderately Obese Patients With Type 2 Diabetes

Author Affiliations
  • 1Imperial College London School of Medicine, London, England
  • 2Cardiff University School of Medicine, Cardiff, Wales
JAMA Surg. 2021;156(2):204-205. doi:10.1001/jamasurg.2020.5177

To the Editor We read with interest the study published by Cohen et al.1 This was a randomized clinical trial comparing the benefits of Roux-en-Y gastric bypass (RYGB) with best medical treatment (BMT) for chronic kidney disease in patients with type 2 diabetes and grade 1 obesity (body mass index of 30-35; calculated as weight in kilograms divided by height in meters squared).1 The authors concluded that RYGB is more effective at achieving microalbuminuria remission after 24 months and demonstrated it is a safe procedure with similar adverse effects to medical management.

Add or change institution